Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd. is a South Korea-based company in the Healthcare sector with a market capitalisation of $50.1B. Its FinScore is 64/100; its highest-scoring layer is Quality (77) and its lowest is Momentum (31). The shares trade at 30.5x trailing earnings and are down 23% year to date.
Share price performance
About Samsung Biologics Co.,Ltd.
samsungbiologics.comSamsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon, South Korea, provides contract services for biopharmaceutical products. The company's operations are divided into two main segments: Contract Manufacturing Organization (CMO) and Contract Development Organization (CDO). Its CDO services cover areas such as cell line development, optimization of upstream and downstream processes, and the formulation of analytical methods and final products. For CMO, the company offers aseptic filling, lyophilization, finishing, storage, shipping, and various associated support services. Additionally, it delivers comprehensive quality assurance, quality control, biosafety, and analytical testing. Samsung Biologics is also involved in creating and launching biosimilar drugs, alongside manufacturing mammalian cell-based antibody medications.
- Sector
- Healthcare
- Industry
- Biotechnology
- HQ
- South Korea
- Fiscal year-end
- December
- Trading currency
- KRW
- Reporting currency
- KRW
- Fundamentals updated
- 65 days ago
- Market cap
- $50.1B
- Shares outstanding
- 46.6M
- P/E (TTM)
- 30.5x
- Beta (issuer)
- 0.19
- Revenue (latest FY)
- ₩4.6T
Revenue breakdown
Revenue split not available
FinScore
As of 2026-10-19Snapshot
Ownership
Holder data is not available for this company yet.
Sign up or log in to see Analysis
Analysis for Samsung Biologics Co.,Ltd. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Financials
Financials for Samsung Biologics Co.,Ltd. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Estimates
Estimates for Samsung Biologics Co.,Ltd. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Peers
Peers for Samsung Biologics Co.,Ltd. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Valuation
Valuation for Samsung Biologics Co.,Ltd. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see News
News for Samsung Biologics Co.,Ltd. is available to Finryse members. The Overview stays open to everyone; creating an account is free.